BOT 2.70% 38.0¢ botanix pharmaceuticals ltd

BOT price action, page-35

  1. 701 Posts.
    lightbulb Created with Sketch. 142
    The Analyst isn't wrong, just timed it wrong. The evidence is overwhelming. FDA approved. Minimal side effects. Perma. Patents. Phase 2. I am expecting more than positive results. Looking for Perma deals, partners, OR TO.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.